EX-99.1 2 v439289_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Sapiens Logo notag.jpg

 

 

Sapiens Reports 20.9% Revenue Growth in Q1 2016

 

Net Income Increased by 26.6%

 

Holon, Israel – May 10, 2016 Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the first quarter ended March 31, 2016.

 

First Quarter Highlights:

 

·Non-GAAP revenue of $49.6 million, up 20.9% compared to $41.0 million in the first quarter of 2015.

 

·Non-GAAP operating profit increased by 27.0% and totaled $7.3 million (14.8% operating margin), compared to $5.8 million (14.1% operating margin) in the first quarter of 2015.

 

·Non-GAAP net income attributable to Sapiens’ shareholders totaled $6.0 million, or $0.12 per diluted share. This is an increase of 26.6% compared to $4.7 million, or $0.10 per diluted share, in the first quarter last year.

 

·The Sapiens Board of Directors approved the distribution of a cash dividend of $0.20 per share, representing approximately $9.8 million in the aggregate, to be distributed on June 1, 2016 to its shareholders of record as of May 19, 2016.

 

·Cash, cash equivalents and securities investments as of March 31, 2016 were $98.5 million and the company has no debt.

 

“We saw double-digit growth and improved performance across all of our offerings, from all geographies and from both new and existing customers,” said Roni Al-Dor, president and CEO of Sapiens. “The demand for our products and services remained strong, resulting in a number of significant wins that further expanded our revenue base and enhanced our competitive market position.”

 

Al-Dor continued: “Beyond our new customer wins, we had several ‘go live’ events with major customers during the first quarter. These major events demonstrate our proven ability to deliver our products and services, as well as the ease with which our customers can roll-out and integrate these technologies across their organizations. Sapiens also launched several products and value propositions during the quarter, including our new Sapiens ALIS Fast Track proposition for the UK Protection Market and our advanced analytics solution, Sapiens INTELLIGENCE. INTELLIGENCE is an innovative and fully functional analytics solution that is easily tailored to meet our clients' specific needs to produce actionable insights and maximize the value of their underlying data.”

 

 1

 

 

“More recently, we launched our flagship ALIS solution in the cloud, for life, annuity and pension insurers to provide our customers with a solution deployment option that is agile, scalable and cost-efficient,” continued Al-Dor. “Our new product offerings, and sales and marketing activities reflect our ongoing efforts to expand our global presence and drive continued market share growth. We remain enthusiastic about our near- and long-term prospects and our strategic position as an innovative provider of advanced, industry-leading technology solutions.”

 

Mr. Al-Dor concluded: “Our business plan remains solid and we are confident in our ability to deliver full-year 2016 revenue in line with our guidance of $207 million to $211 million, a growth of 15.4%-17.7%. This includes operating margins in the range of 15.0%-15.5%.”

 

Quarterly Results Conference Call

 

Management will host a conference call and webcast on May 10 at 10:00 a.m. Eastern Time (5:00 p.m. in Israel) to review and discuss Sapiens' results. Please call one of the following numbers (at least 10 minutes before the scheduled time) to participate:

 

North America (toll-free): +1-866-860-9642; International: +972-3-918-0664; UK: 0-800-917-9141

 

The live webcast of the call can be viewed on Sapiens’ website at: http://www.sapiens.com/investors/presentations-and-webcast/

 

If you are unable to join live, a replay of the call will be accessible until May 20, 2016, as follows:

 

North America: +1-888-254-7270; International: +972-3-925-5940. A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

 2

 

 

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

In addition, the Company adjusted revenues and expenses, recorded under US GAAP, of pre-acquisition date in respect of acquired business from its ultimate parent company. As this transaction is between companies under common control, under US GAAP, it was accounted for under the pooling of interest method. For non-GAAP measurement purposes, the Company excludes the pre-acquisition date revenues and expenses.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included in the financial tables of this release.

 

The Company defines adjusted EBITDA as net profit adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, amortization of internal-use software development costs interest expense, compensation expenses related to acquisition, pre-acquisition revenues and expenses accounted under pooling of interest method, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

 

 3

 

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 190 financial services organizations. The Sapiens team of approximately 1,700 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

 

 

Forward-Looking Statement

 

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

 

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2015, and subsequent reports and registration statements filed periodically with the Securities and Exchange Commission.

 

 

Investors and Media Contact:

 


Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of Corporate Communications

Sapiens International

U.S. Mobile: +1-201-250-9414

Mobile: +972-54-9099039

Email: yaffa.cohen-ifrah@sapiens.com

 

 4

 

 

Summary of Non-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

   Three months ended 
   March 31, 
   2016   2015 
   (unaudited)   (unaudited) 
                 
Revenues   49,567    100%   41,014    100%
Gross profit   21,574    43.5%   17,678    43.1%
Operating profit   7,348    14.8%   5,788    14.1%
Net income to shareholders   5,986    12.1%   4,727    11.5%
Adjusted EBITDA   7,955    16.0%   6,178    15.1%
Basic earnings per share   0.12         0.10      
Diluted earnings per share   0.12         0.10      

 

Non-GAAP revenues by geographic breakdown
U.S. dollars in thousands

 

   Q1 2016   Q4 2015   Q3 2015   Q2 2015   Q1 2015 
                          
North America   16,041    16,767    16,571    14,294    13,700 
Europe   28,421    26,439    24,084    23,743    23,153 
APAC   5,105    5,468    5,484    5,399    4,161 
                          
Total   49,567    48,674    46,139    43,436    41,014 

 

 5

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

    Three months ended
    March 31,
    2016     2015*  
    (unaudited)     (unaudited)  
             
Revenue     49,567       43,861  
Cost of revenue     29,607       26,450  
                 
Gross profit     19,960       17,411  
                 
Operating Expenses:                
Research and development, net     3,253       2,621  
Selling, marketing, general and administrative     10,456       8,992  
Total operating expenses     13,709       11,613  
                 
Operating income     6,251       5,798  
                 
                 
Financial expenses (income), net     (80 )     330  
Taxes and other expenses, net     1,458       681  
                 
                 
Net Income     4,873       4,787  
                 
Attributable to non-controlling interest     (14 )     58  
                 
Net income attributable to Sapiens' shareholders     4,887       4,729  
                 
                 
Basic earnings per share     0.10       0.10  
                 
Diluted earnings per share     0.10       0.10  
                 
                 
Weighted Average Number of Shares Outstanding Used to Compute Basic Earnings per Share (in thousands)     48,819       47,707  
Weighted Average Number of Shares Outstanding Used to Compute Diluted Earnings per Share (in thousands)     49,560       48,894  

 

*Including consolidation of Insseco, commencing December 31, 2014.

 

 6

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended 
   March 31, 
   2016   2015 
GAAP revenue   49,567    43,861 
Adjustments of pre-acquisition revenue accounted under pooling of interest method   -    (2,847)
Non-GAAP revenue   49,567    41,014 
           
           
GAAP gross profit   19,960    17,411 
Revenue adjustment   -    (2,847)
Amortization of capitalized software   1,409    1,215 
Amortization of other intangible assets   205    194 
Adjustments of pre-acquisition cost of revenue accounted under pooling of interest method   -    1,705 
Non-GAAP gross profit   21,574    17,678 
           
           
GAAP operating income   6,251    5,798 
Gross profit adjustments   1,614    267 
Capitalization of software development   (1,384)   (1,312)
Amortization of other intangible assets   306    327 
Stock-based compensation   458    278 
Compensation related to acquisition   103    - 
Adjustments of pre-acquisition operating expenses accounted under pooling of interest method   -    430 
Non-GAAP operating income   7,348    5,788 
           
           
GAAP net income attributable to Sapiens' shareholders   4,887    4,729 
Operating income adjustments   1,097    (10)
Adjustment to redeemable non-controlling interest   66    - 
Adjustments of pre-acquisition financial and tax expenses accounted under pooling of interest method   -    142 
Other   (64)   (134)
Non-GAAP net income attributable to Sapiens' shareholders   5,986    4,727 
           
           
           
Non-GAAP basic earnings per share   0.12    0.10 
           
Non-GAAP diluted earnings per share   0.12    0.10 
           
           
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   48,819    47,707 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,560    48,894 

 

 7

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

 

   March 31,   December 31, 
   2016   2015 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS:          
Cash and cash equivalents   58,679    54,351 
Trade receivables, net   37,137    29,761 
Other receivables and prepaid expenses   5,652    5,455 
Marketable securities   23,297    8,776 
           
Total current assets   124,765    98,343 
           
LONG-TERM ASSETS:          
Marketable securities   16,542    30,875 
Property and equipment, net   6,594    5,675 
Severance pay fund   5,035    5,551 
Other intangible assets, net   27,714    27,540 
Other long-term assets   4,733    4,252 
Goodwill   71,636    70,035 
           
Total long-term assets   132,254    143,928 
           
TOTAL ASSETS   257,019    242,271 
           
Liabilities and Equity          
           
CURRENT LIABILITIES:          
Trade payables   5,564    4,721 
Accrued expenses and other liabilities   32,536    32,012 
Dividend payables   9,786    - 
Deferred revenue   13,442    10,268 
           
Total current liabilities   61,328    47,001 
           
LONG-TERM LIABILITIES:          
Other long-term liabilities   7,197    6,414 
Accrued severance pay   6,145    6,662 
           
Total long-term liabilities   13,342    13,076 
           
           
REDEEMABLE NON-CONTROLLING INTEREST   385    385 
           
EQUITY   181,964    181,809 
           
TOTAL LIABILITIES AND EQUITY   257,019    242,271 

 

 8

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

  

For the 3 months ended

March 31

 
   2016   2015* 
   (unaudited)   (unaudited) 
Cash flows from operating activities:        
Net income   4,873    4,787 
Reconciliation of net income to net cash provided by operating activities:          
Depreciation  and amortization   2,527    2,170 
Amortization of premium and accrued interest on marketable securities   (134)   (99)
Stock-based compensation related to options issued to employees   458    278 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Trade receivables   (6,682)   2,699 
Deferred tax assets   107    745 
Other operating assets   (227)   (749)
Trade payables   419    1,511 
Other operating liabilities   98    (708)
Deferred revenues   3,052    1,050 
Severance pay   (34)   (156)
           
Net cash provided by operating activities   4,457    11,528 
           
Cash flows from investing activities:          
Purchase of property and equipment   (849)   (894)
Interest received, net of purchase of marketable securities   99    286 
Capitalized software development costs   (1,384)   (1,312)
Restricted cash   (2)   (1,809)
           
Net cash used in investing activities   (2,136)   (3,729)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   473    223 
Payment to shareholders in respect of acquisition   -    74 
           
Net cash provided by financing activities   473    297 
           
Effect of exchange rate changes on cash and cash equivalents   1,534    (1,552)
           
Increase in cash and cash equivalents   4,328    6,544 
Cash and cash equivalents at the beginning of period   54,351    47,400 
           
Cash and cash equivalents at the end of period   58,679    53,944 

 

*Including consolidation of Insseco, commencing December 31, 2014.

 

 9

 


Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended 
   March 31, 
   2016   2015 
         
GAAP operating profit   6,251    5,798 
           
Non-GAAP adjustments:          
Amortization of capitalized software   1,409    1,215 
Amortization of other intangible assets   511    521 
Capitalization of software development   (1,384)   (1,312)
Compensation related to acquisition   103    - 
Stock-based compensation   458    278 
Adjustments of pre-acquisition revenues and expenses accounted under pooling of interest method   -    (712)
           
Non GAAP operating profit   7,348    5,788 
           
Depreciation   607    390 
           
Adjusted EBITDA   7,955    6,178 

 

 10